Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.

Journal of clinical pathology - 1 Aug 2018

De Luca Caterina, Rappa Alessandra G, Gragnano Gianluca, Malapelle Umberto, Troncone Giancarlo, Barberis Massimo

Abstract excerpt

AIMS: Any reference laboratory testing non-small cell lung cancer samples for predictive biomarkers needs to develop and validate a wide range of different molecular techniques, each with a specific time requirement and application. Updated international guidelines suggest that next generation sequencing (NGS) to be the initial procedure. However, in a non-negligible subset of cases, library generation may fail...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to Automation, Laboratory

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to High-Throughput Nucleotide Sequencing

Share to Predictive Value of Tests

Share to Real-Time Polymerase Chain Reaction

Share to Reproducibility of Results

Source

Identifiers

PMID: 29798838
DOI: 10.1136/jclinpath-2018-205197

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.PMID 29798838Read ↗

Use of the Idylla EGFR Mutation Test for Variant Detection in Non-Small Cell Lung Cancer Samples.Semantic proximity Read ↗

Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results.Semantic proximity Read ↗

Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients.Semantic proximity Read ↗

Evaluation of the Idylla system to detect the EGFRT790M mutation using extracted DNA.Semantic proximity Read ↗

[EGFR molecular characterization in non-small cell bronchic cancer: comparative prospective study by NGS and Idylla platform technologies].Semantic proximity Read ↗

Performance evaluation of the Biocartis Idylla EGFR Mutation Test using pre-extracted DNA from a cohort of highly characterised mutation positive samples.Semantic proximity Read ↗

Rapid EGFR evaluation from used H&E, IHC and FISH diagnostic slides with the Idylla platform.Semantic proximity Read ↗

Feasibility of EGFR Mutation Testing Without Nucleic Acid Extraction in Scraped Cytologic Samples Using the Idylla Platform.Semantic proximity Read ↗

Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung CancerSemantic proximity Read ↗

Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot studySemantic proximity Read ↗

Rapid clinical mutational testing of KRAS, BRAF and EGFR: a prospective comparative analysis of the Idylla technique with high-throughput next-generation sequencingSemantic proximity Read ↗

Comparison of Biocartis IDYLLA ™ cartridge assay with Qiagen GeneReader NGS for detection of targetable mutations in EGFR, KRAS/NRAS, and BRAF genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.